Opioid Indications Under TGA Scrutiny As Australia Tackles Growing Misuse
Executive Summary
The Australian drug regulator is reviewing the indications, pack sizes and information documents for consumers of potent opioid products to see how misuse and overdoses can be prevented.
You may also be interested in...
US FDA To Withdraw Pain Drug Guidance As Part Of Response To Opioid Epidemic
"At least four" guidances will replace it, Commissioner Gottlieb notes in frank update which states "I don’t want to look back ten years from now and wish there were more policies we had pursued, or more steps we had taken, to stop the advance of this crisis."
Eradicating ‘Indication Creep’ One Of Eight Australian Proposals To Tackle Opioid Misuse
Australian regulators are proposing to review the indications of strong opioids to see if they are appropriate, according to one of eight regulatory options for addressing the growing problem of opioid misuse in the country.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.